Financing - October 17, 2022
Exact Therapeutics awarded 16 million NOK
Exact Therapeutics has announced that its collaboration partner GE Healthcare has been awarded with an innovation grant from the Norwegian Research Council (NRC) of 16 million NOK to support the development of a ready-to-use formulation of Sonazoid for ultrasound imaging and therapy. “We are very pleased with the award of this NRC grant, which brings […]
Business - October 11, 2022
Unlocking the full value potential in digital pathology
DoMore Diagnostics, one of our NLS Stars 2022, aims to change the one-size-fits-all approach in cancer therapy. Cancer is a growing global public health problem, and the cost of cancer care is expected to double the next 20 years. It is a leading cause of death worldwide and accounted for nearly 10 million deaths in […]
Uncategorized - September 29, 2022
New Norwegian centre for precision immunotherapy
The centre, called Precision Immunotherapy Alliance (PRIMA), is led by Johanna Olweus, Professor and Head of Department of Cancer Immunology at Oslo University Hospital and Karl-Johan Malmberg, Professor at the University of Oslo. Nine new Centers of Excellence have been awarded 1.4 billion NOK by the Norwegian Research Council. One of the centers will focus […]
Profiles in Business - August 8, 2022
Jutta Heix: Advancing the oncology innovation ecosystem
For the past 14 years Jutta Heix has been an important cog in the wheel in accelerating the development of new cancer treatments and diagnostics – connecting and helping innovators and putting Norwegian oncology on the global map.
Clinical Trials - July 4, 2022
Ultimovacs completes patient recruitment in Phase II trial
Ultimovacs has announced the completed recruitment of 154 patients in the INITIUM trial. INITIUM is Ultimovacs’ Phase II clinical trial of its universal cancer vaccine UV1 in combination with the checkpoint inhibitors ipilimumab and nivolumab in metastatic malignant melanoma. Consistent with INITIUM’s event-driven design, topline progression-free survival results will be disclosed after progression of cancer […]
Collaboration - June 28, 2022
Reinforced Swedish-Norwegian cancer cooperation
A Memorandum of Understanding (MoU) was signed between the University of Oslo and the Karolinska Institute during a visit by the Norwegian Crown Prince Couple and a Norwegian industry delegation in Stockholm on 2 May. “Norway and Sweden must work together towards making precision medicine a standard for all cancer patients,” says Ketil Widerberg, general […]
